Myeloid leukemia

Results: 723



#Item
101Eisai and Janssen Announce the Presentation of DACOGEN® (decitabine) Data at ASCO from a Phase III Study in Patients with Acute Myeloid Leukemia Data from DACO-016 study at 2011 American Society of Clinical Oncology Ann

Eisai and Janssen Announce the Presentation of DACOGEN® (decitabine) Data at ASCO from a Phase III Study in Patients with Acute Myeloid Leukemia Data from DACO-016 study at 2011 American Society of Clinical Oncology Ann

Add to Reading List

Source URL: astx.com

Language: English
102January 2, 2013 Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Advanced Hepatocellular Carcinoma (HCC) Patients DUBLIN, Calif., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasda

January 2, 2013 Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Advanced Hepatocellular Carcinoma (HCC) Patients DUBLIN, Calif., Jan. 2, 2013 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasda

Add to Reading List

Source URL: astx.com

Language: English
103September 28, 2012 DACOGEN(R) Approved in the European Union for the Treatment of Acute Myeloid Leukemia New Treatment Offers Clinically Significant Benefit for Patients DUBLIN, Calif., Sept. 28, 2012 (GLOBE NEWSWIRE) -

September 28, 2012 DACOGEN(R) Approved in the European Union for the Treatment of Acute Myeloid Leukemia New Treatment Offers Clinically Significant Benefit for Patients DUBLIN, Calif., Sept. 28, 2012 (GLOBE NEWSWIRE) -

Add to Reading List

Source URL: astx.com

Language: English
104June 20, 2013 Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO) Correlation of Biomarkers and DNA Methylation to Clinical Responses DUBLIN, Cali

June 20, 2013 Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Data at the Upcoming European Cancer Congress (ECCO-ESMO-ESTRO) Correlation of Biomarkers and DNA Methylation to Clinical Responses DUBLIN, Cali

Add to Reading List

Source URL: astx.com

Language: English
105August 28, 2013 Astex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study SGI-110 Phase 2 Shows Clear Activity in Patients With Acute Myeloid Leukemia DUBLIN, Calif., Aug. 28, 2013 (GLOBE NEWSWIRE) --

August 28, 2013 Astex Pharmaceuticals Announces Topline Results of SGI-110 AML Phase 2 Study SGI-110 Phase 2 Shows Clear Activity in Patients With Acute Myeloid Leukemia DUBLIN, Calif., Aug. 28, 2013 (GLOBE NEWSWIRE) --

Add to Reading List

Source URL: astx.com

Language: English
106Haematology Clinical Trials The Department of Haematology at Flinders Medical Centre has a Clinical Trials Unit for research into the diagnosis, monitoring, and treatment of haematological disorders. This includes both b

Haematology Clinical Trials The Department of Haematology at Flinders Medical Centre has a Clinical Trials Unit for research into the diagnosis, monitoring, and treatment of haematological disorders. This includes both b

Add to Reading List

Source URL: www.fcic.org.au

Language: English - Date: 2014-02-25 19:14:38
107FDA Accepts DACOGEN(R) (Decitabine) sNDA Submission in Acute Myeloid Leukemia DUBLIN, Calif., Jul 13, 2011 (BUSINESS WIRE) -SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and developmen

FDA Accepts DACOGEN(R) (Decitabine) sNDA Submission in Acute Myeloid Leukemia DUBLIN, Calif., Jul 13, 2011 (BUSINESS WIRE) -SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and developmen

Add to Reading List

Source URL: astx.com

Language: English
108Astex Pharmaceuticals Announces Subcutaneous SGI-110 Interim Phase 1/2 MDS and AML Data Presentation at AACR DUBLIN, Calif., April 3, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical c

Astex Pharmaceuticals Announces Subcutaneous SGI-110 Interim Phase 1/2 MDS and AML Data Presentation at AACR DUBLIN, Calif., April 3, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical c

Add to Reading List

Source URL: astx.com

Language: English
109November 20, 2012 Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Results From Phase 1/2 MDS and AML Study at ASH DUBLIN, Calif., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX),

November 20, 2012 Astex Pharmaceuticals Announces Oral Presentation of SGI-110 Results From Phase 1/2 MDS and AML Study at ASH DUBLIN, Calif., Nov. 20, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX),

Add to Reading List

Source URL: astx.com

Language: English
110Survival of cancer patients in Northern Ireland: [removed]: LEUKAEMIA (C91-C95; ADULTS ONLY) KEY FACTS: • 87 male and 64 female cases diagnosed each year during[removed]with no significant change in male or femal

Survival of cancer patients in Northern Ireland: [removed]: LEUKAEMIA (C91-C95; ADULTS ONLY) KEY FACTS: • 87 male and 64 female cases diagnosed each year during[removed]with no significant change in male or femal

Add to Reading List

Source URL: www.qub.ac.uk

Language: English - Date: 2013-06-26 08:00:19